|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuasa-Nakagawa K, Shibuya H, Yoshimura R,
Miura M, Watanabe H, Kishimoto S and Omura K: Cervical lymph node
metastasis from early-stage squamous cell carcinoma of the oral
tongue. Acta Otolaryngol. 133:544–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hauswald H, Zwicker F, Rochet N, Jensen
AD, Debus J and Lindel K: Treatment of squamous cell carcinoma of
the mobile tongue or tongue margins: An interdisciplinary
challenge. Acta Oncol. 52:1017–1021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yeung K, Seitz T, Li S, Janosch P,
McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, et
al: Suppression of Raf-1 kinase activity and MAP kinase signalling
by RKIP. Nature. 401:173–177. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yeung K, Janosch P, McFerran B, Rose DW,
Mischak H, Sedivy JM and Kolch W: Mechanism of suppression of the
Raf/MEK/extracellular signal-regulated kinase pathway by the raf
kinase inhibitor protein. Mol Cell Biol. 20:3079–3085. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yeung KC, Rose DW, Dhillon AS, Yaros D,
Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W and Sedivy
JM: Raf kinase inhibitor protein interacts with NF-kappaB-inducing
kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol.
21:7207–7217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Corbit KC, Trakul N, Eves EM, Diaz B,
Marshall M and Rosner MR: Activation of Raf-1 signaling by protein
kinase C through a mechanism involving Raf kinase inhibitory
protein. J Biol Chem. 278:13061–13068. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lorenz K, Lohse MJ and Quitterer U:
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to
GRK-2. Nature. 426:574–579. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Fu Z, Binkley C, Giordano T,
Burant CF, Logsdon CD and Simeone DM: Raf kinase inhibitory protein
inhibits beta-cell proliferation. Surgery. 136:708–715. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schuierer MM, Heilmeier U, Boettcher A,
Ugocsai P, Bosserhoff AK, Schmitz G and Langmann T: Induction of
Raf kinase inhibitor protein contributes to macrophage
differentiation. Biochem Biophys Res Commun. 342:1083–1087. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McHenry KT, Montesano R, Zhu S, Beshir AB,
Tang HH, Yeung KC and Fenteany G: Raf kinase inhibitor protein
positively regulates cell-substratum adhesion while negatively
regulating cell-cell adhesion. J Cell Biochem. 103:972–985. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shin SY, Rath O, Zebisch A, Choo SM, Kolch
W and Cho KH: Functional roles of multiple feedback loops in
extracellular signal-regulated kinase and Wnt signaling pathways
that regulate epithelial-mesenchymal transition. Cancer Res.
70:6715–6724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu Z, Smith PC, Zhang L, Rubin MA, Dunn
RL, Yao Z and Keller ET: Effects of raf kinase inhibitor protein
expression on suppression of prostate cancer metastasis. J Natl
Cancer Inst. 95:878–889. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hagan S, Al-Mulla F, Mallon E, Oien K,
Ferrier R, Gusterson B, García JJ and Kolch W: Reduction of Raf-1
kinase inhibitor protein expression correlates with breast cancer
metastasis. Clin Cancer Res. 11:7392–7397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schuierer MM, Bataille F, Weiss TS,
Hellerbrand C and Bosserhoff AK: Raf kinase inhibitor protein is
downregulated in hepatocellular carcinoma. Oncol Rep. 16:451–456.
2006.PubMed/NCBI
|
|
16
|
Al-Mulla F, Hagan S, Behbehani AI, Bitar
MS, George SS, Going JJ, García JJ, Scott L, Fyfe N, Murray GI and
Kolch W: Raf kinase inhibitor protein expression in a survival
analysis of colorectal cancer patients. J Clin Oncol. 24:5672–5679.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chatterjee D, Sabo E, Tavares R and
Resnick MB: Inverse association between Raf Kinase Inhibitory
Protein and signal transducers and activators of transcription 3
expression in gastric adenocarcinoma patients: Implications for
clinical outcome. Clin Cancer Res. 14:2994–3001. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang C, Liu X, Huang H, Ma H, Cai W, Hou
J, Huang L, Dai Y, Yu T and Zhou X: Deregulation of Snai2 is
associated with metastasis and poor prognosis in tongue squamous
cell carcinoma. Int J Cancer. 130:2249–2258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eves EM, Shapiro P, Naik K, Klein UR,
Trakul N and Rosner MR: Raf kinase inhibitory protein regulates
aurora B kinase and the spindle checkpoint. Mol Cell. 23:561–574.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bement WM: A role for RKIP in cell
motility. Chem Biol. 12:953–954. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Odabaei G, Chatterjee D, Jazirehi AR,
Goodglick L, Yeung K and Bonavida B: Raf-1 kinase inhibitor
protein: Structure, function, regulation of cell signaling and
pivotal role in apoptosis. Adv Cancer Res. 91:169–200. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Al-Mulla F, Bitar MS, Al-Maghrebi M,
Behbehani AI, Al-Ali W, Rath O, Doyle B, Tan KY, Pitt A and Kolch
W: Raf kinase inhibitor protein RKIP enhances signaling by glycogen
synthase kinase-3β. Cancer Res. 71:1334–1343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R,
Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, et al:
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a
novel prognostic marker in prostate cancer. Prostate. 66:248–256.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martinho O, Simões K, Longatto-Filho A,
Jacob CE, Zilberstein B, Bresciani C, Gama-Rodrigues J, Cecconello
I, Alves V and Reis RM: Absence of RKIP expression is an
independent prognostic biomarker for gastric cancer patients. Oncol
Rep. 29:690–696. 2013.PubMed/NCBI
|
|
25
|
Song SP, Zhang SB, Li ZH, Zhou YS, Li B,
Bian ZW, Liao QD and Zhang YD: Reduced expression of Raf kinase
inhibitor protein correlates with poor prognosis in pancreatic
cancer. Clin Transl Oncol. 14:848–852. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Afonso J, Longatto-Filho A, Martinho O,
Lobo F, Amaro T, Reis RM and Santos LL: Low RKIP expression
associates with poor prognosis in bladder cancer patients. Virchows
Arch. 462:445–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martinho O, Granja S, Jaraquemada T,
Caeiro C, Miranda-Gonçalves V, Honavar M, Costa P, Damasceno M,
Rosner MR, Lopes JM and Reis RM: Downregulation of RKIP is
associated with poor outcome and malignant progression in gliomas.
PLoS One. 7:e307692012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo W, Dong Z, Guo Y, Lin X, Chen Z, Kuang
G and Yang Z: Aberrant methylation and loss expression of RKIP is
associated with tumor progression and poor prognosis in gastric
cardia adenocarcinoma. Clin Exp Metastasis. 30:265–275. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Al-Mulla F, Hagan S, Al-Ali W, Jacob SP,
Behbehani AI, Bitar MS, Dallol A and Kolch W: Raf kinase inhibitor
protein: Mechanism of loss of expression and association with
genomic instability. J Clin Pathol. 61:524–529. 2008. View Article : Google Scholar : PubMed/NCBI
|
